期刊首页 优先出版 当期阅读 过刊浏览 作者中心 关于期刊 English

2017年 第11卷 第4期

摘要

关键词

相关研究

回顶部

《化学科学与工程前沿（英文）》 >> 2017年 第11卷 第4期 doi: 10.1007/s11705-017-1640-4

Nanovaccines for remodeling the suppressive tumor microenvironment: New horizons in cancer immunotherapy

. Division of Molecular Pharmaceutics and Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.. Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China

录用日期： 2017-05-10 发布日期： 2017-11-06
HTML16 PDF 4 收藏 0

下一篇 上一篇

摘要

Despite limited successes in clinical development, therapeutic cancer vaccines have experienced resurgence in recent years due to an enhanced emphasis upon co-mitigating factors underlying immune response. Specifically, reversing the immune-suppressive effects of the tumor microenvironment, mediated by a variety of cellular and molecular signaling mechanisms, has become fundamental toward enhancing therapeutic efficacy. Therein, our lab has implemented various nano-vaccines based on the lipid-coated calcium phosphate platform for combined immunotherapy, in which antigenic, epitope-associated peptides as well as immune-suppression inhibitors can be co-delivered, often functioning through the same formulation. In probing the mechanism of action of such systems and , an improved effect synergy can be elucidated, inspiring future preclinical efforts and hope for clinical success.

相关研究